The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...
A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...
The Brighterside of News on MSN1d
Breakthrough mRNA vaccine reinvents pancreatic cancer treatmentLong before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...
Pancreatic cancer is a serious illness that starts in the pancreas, an organ located behind the stomach. The pancreas is ...
Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...
A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic ...
Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...
News-Medical.Net on MSN4d
Neuropeptide Y identified as key driver of pancreatic cancer spreadResearchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback